Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase 2b Advance-HTN trial. The post Lorundrostat Represents Novel Class of BP-Lowering Drugs first appeared on […]
The post Lorundrostat Represents Novel Class of BP-Lowering Drugs first appeared on Blackandmed .
